venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 6
- −1 vs. Q4 2022
- Portfolio value
- $180.4M
- −$142.1M (−44.1%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VTYXVentyx Biosciences, Inc. | COM | 2,298,833 | $77.0M | 42.7% | −1,162,703−33.6% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $43.8M | 24.3% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $33.8M | 18.7% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 2,278,575 | $18.4M | 10.2% | −18,135−0.8% | Reduced | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $3.86M | 2.1% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,866,339 | $3.55M | 2.0% | 00.0% | Unchanged | History |
Sold out since Q4 2022 (1)
Positions held at the end of Q4 2022 that are gone from this filing.